Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- CHL -2.7%, ACN -2.6%, KDMN -2.4%, CAG -1.9%, ASND -1.5%, BGNE -0.6%, EHIC -0.5%
Other news:
- TNDM -22.6% (prices offering of 18 mln shares at $1.25/share)
- HTBX -20.4% (prices underwritten public offering of 5 mln shares of its common stock at $0.80/share)
- QUIK -12.2% (prices 10 mln common stock offering at $1.50/share)
- OEC -8.3% (announces that Kinove Luxembourg Holdings and certain other sellers intend to offer an aggregate of 5 mln common shares in an underwritten public offering)
- RARE -6.9% (announces topline data from the Phase 2 study of UX007 in glucose transporter type-1 deficiency syndrome patients with seizures; study did not meet the primary endpoint)
- VNCE -5.3% (following late move higher)
- BLCM -4.3% (commences an underwritten public offering of 5,000,000 shares of its common stock)
- SHLD -3.9% (continued weakness)
- CHMI -3.8% (commences 4.5 mln common stock offering)
- ENPH -3.2% (files for approx 12 mln share common stock offering by selling shareholder)
- MMSI -3% (prices offering of 4.5 mln shares of common stock at $28.25 per share)
- KEYS -1.6% (offering of 11,428,571 common shares at $35.00 per share)
- MYL -0.9% ( indicated lower in after hours on EpiPen recall news)
Analyst comments:
- WLL -1.7% (downgraded to Sell from Neutral at UBS)
- GPOR -1.6% (downgraded to Neutral from Buy at Goldman)
- DG -1.2% (downgraded to Underperform from Neutral at Credit Suisse)
- NSC -1.1% (downgraded to Underperform at RBC Capital Mkts)
- MO -1.1% (downgraded to Underperform at RBC Capital Mkts)
- PEGI -1% (downgraded to Neutral from Outperform at Macquarie)